Zhejiang Shenghua Biok Biology

Zhejiang Shenghua Biok Biology, currently operating as Zhejiang Hanye, is a leading Chinese enterprise specializing in the research, development, and large-scale manufacturing of veterinary drugs, feed additives, and agrochemicals. The company is recognized as one of the world's largest production bases for fermentation-derived products, including abamectin, ivermectin, and various ionophore coccidiostats. Its core business focuses on animal health and crop protection, leveraging advanced microbial fermentation technology to produce high-quality antiparasitics and antibiotics. Publicly listed on the Shanghai Stock Exchange since 1999, the company serves a global market, providing essential pharmaceutical intermediates and finished products for livestock and agriculture.